Assesment of functional gastrointestinal diseases in obese children

Umit Kiyak1, Nafiye Urganci2, Merve Usta3

  • 1SBU Sisli Hamidiye Etfal Training and Research Hospital, Pediatrics, MD, Istanbul, Turkey.

PubMed

Insights

Obese children experience significantly higher rates of functional gastrointestinal disorders (FGID). Early assessment of these gut-brain interaction symptoms in pediatric obesity can prevent unnecessary medical tests.

Area of Science:

  • Pediatric Gastroenterology
  • Obesity Research
  • Gut-Brain Interactions

Background:

  • Functional gastrointestinal disorders (FGID) are increasingly recognized as prevalent in obese populations.
  • FGID are characterized by chronic gastrointestinal symptoms stemming from gut-brain interaction issues.

Purpose of the Study:

  • To investigate the prevalence and characteristics of FGID in a cohort of obese children.
  • To compare FGID rates between obese and non-obese children.

Main Methods:

  • A cross-sectional study involving 405 children aged 6-18 years.
  • Children were categorized based on Body Mass Index (BMI) percentiles (<85th and >95th).
  • FGID diagnosis utilized the ROME VI criteria, with detailed demographic and clinical evaluations.

Main Results:

  • Over half of the children (50.6%) had a BMI >95th percentile, with 55.1% of these experiencing FGID.
  • Functional abdominal pain disorders and functional defecation disorders were significantly more prevalent in obese children (P < 0.01).
  • Constipation-predominant IBS, diarrhea-predominant IBS, functional diarrhea, and abdominal distention were also significantly higher in the obese group (P < 0.01).

Conclusions:

  • FGID are significantly more common in obese children compared to their non-obese peers.
  • Routine assessment for functional gastrointestinal symptoms in obese children is recommended to avoid unnecessary investigations.
  • These findings highlight the critical link between pediatric obesity and gut-brain dysfunction.

Related Concept Videos

Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
224
Assessment of the Gastrointestinal System II: Health Perception Pattern01:29

Assessment of the Gastrointestinal System II: Health Perception Pattern

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
140
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
188
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
434
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
111